ID: ALA3683746

Max Phase: Preclinical

Molecular Formula: C29H28F4N4O6

Molecular Weight: 604.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(OCC3CCCO3)cc12

Standard InChI:  InChI=1S/C29H28F4N4O6/c1-15(38)27-19-12-17(42-14-18-4-3-9-41-18)7-8-21(19)36(35-27)13-25(39)37-22-10-16(22)11-23(37)28(40)34-20-5-2-6-24(26(20)30)43-29(31,32)33/h2,5-8,12,16,18,22-23H,3-4,9-11,13-14H2,1H3,(H,34,40)/t16-,18?,22-,23+/m1/s1

Standard InChI Key:  PNOSDGFOWUNNAC-NQGDMDSPSA-N

Associated Targets(Human)

Complement factor D 1353 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 604.56Molecular Weight (Monoisotopic): 604.1945AlogP: 4.46#Rotatable Bonds: 9
Polar Surface Area: 111.99Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.27CX Basic pKa: CX LogP: 3.80CX LogD: 3.80
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.28Np Likeness Score: -1.00

References

1.  (2015)  Complement pathway modulators and uses thereof, 

Source

Source(1):